A160 Treatment of cervical ICA dissections with the CARESTO heal stent – a case series of six patients

<h3>Introduction</h3> Cervical internal carotid artery (ICA) dissections are a significant cause of ischemic stroke, particularly in younger patients. While many cases are managed conservatively, endovascular treatment may be necessary for cases with hemodynamic compromise or embolic risk. <h3>Aim of Study</h3> This study aimed to assess the safety and efficacy of the CARESTO heal stent in treating cervical ICA dissections. <h3>Method</h3> Between August 2024 and May 2025, six patients (aged 40–80) with high-grade cervical ICA dissections were treated at our center. Indications for intervention included persistent flow limitation, progressive symptoms, or contraindications to anticoagulation. The CARESTO heal stent, a highly flexible, self-expanding nitinol stent with a bioactive surface coating, was implanted under dual antiplatelet therapy. <h3>Results</h3> Stent deployment was successful in all cases without periprocedural complications. Current Follow-up imaging showed vessel remodeling and maintained stent patency. No in-stent stenosis, thromboembolic events, or neurological deterioration occurred. All patients remained asymptomatic after the procedure. <h3>Conclusion</h3> The CARESTO heal stent demonstrated a favorable safety and efficacy profile in treating cervical ICA dissections. These promising initial results support the need for further investigation in larger, prospective clinical trials. <h3>Conflict of Interest</h3> No